The chemokine receptor CXCR4
2025-03-12
CXCR4, also known as CD184, is a CXC chemokine receptor type 4, a class A G protein-coupled receptor (GPCR). It is activated by chemotactic ligands and participates in regulating h...
Immune Sentinel TLR4
2025-03-11
Toll-like receptor 4 (TLR4) is a transmembrane receptor that plays a key role in the innate immune system. It recognizes pathogen-associated molecular patterns (PAMPs) and damage-a...
YAbS:The Antibody Society’s antibody therapeutics database
2025-03-10
BackgroundTherapeutic antibodies have garnered significant attention in recent years for their precise ability to target specific diseases. As these molecules become increasingly i...
The pleiotropic cytokine IL9
2025-03-07
Interleukin 19 (IL19), a member of the IL-2RγC chain family, is a pleiotropic cytokine that regulates the functions of various cells. Originally identified as a growth factor for T...
Dual inhibition of a novel bispecific antibody CDX-622
2025-03-05
BackgroundBiologically based therapies targeting cytokine pathways have demonstrated significant clinical benefit in a number of inflammatory and autoimmune diseases. Many of these...
The target of tumor immunotherapy is MUC1
2025-03-03
Mucin1 (MUC1, also known as EMA, MCD, PEM, PUM, KL-6, and MAM6) is a large protein. It is the most recognizable transmembrane protein in the mucin family and has a heavily glycosyl...
De novo designed proteins neutralize lethal snake venom toxins
2025-02-25
BackgroundSnakebite envenomation is a devastating and neglected tropical disease that causes severe complications and disability in humans. Three-finger toxin (3FTx), the highly to...